Subsequent immunohistochemistry (IHC) analysis using C-PRSS35 antibody also showed a gradual reduction in PRSS35 levels with increasing stage of HCC development (Supplementary Fig. 1e and Supplementary Tables 1, 2). This evidence concerns the gene PRSS35 and hepatocellular carcinoma.